MedAdherence provides an automated communication system using cloud and mobile technologies that enables doctors to monitor patients and intervene remotely with customized messages delivered via cell phones, landlines, text messaging and the Internet. The platform is intended for patients with chronic illnesses such as diabetes, hypertension, heart disease, asthma and inflammatory bowel disease, as well as for maternal/prenatal health and HIV/AIDS care. Led by CEO and founder Jonathan Katz, the company is conducting pilot projects with Tulane University School of Medicine, Montefiore Medical Center, University of Maryland Medical Center and University of Mississippi Medical Center. MedAdherence is also a partner of Verizon Wireless. Financially, the company raised $200K in funding from Connecticut Innovations' Pre-Seed Fund, which had previously committed $150K in 2011. MedAdherence offers an automated remote patient-adherence system that lets clinicians monitor patients’ adherence to care plans and intervene through cell phones, text messaging and the Internet. The technology is positioned to assist patients with chronic illnesses such as diabetes, heart disease and asthma. The company has partnered with Verizon Wireless to support a new mobile healthcare initiative. MedAdherence is led by CEO and founder Jonathan Katz and has completed beta testing engagements, including with Tulane University School of Medicine. The company intends to use recent financing to continue development, complete current beta testing and secure additional customers. Financially, it has secured external capital via a Pre-Seed financing and matching private investment commitments to fund these activities.

Total raised

$0M

Funding rounds

2

Latest round

Seed

Latest activity

Feb 2013